About this episode
Jan 14
Understanding LAM: Insights into this Rare Lung Disease
In this episode of the Respiratory Exchange podcast, Dr. Les Tolle and Dr. Kamonpun (Joy) Ussavarungsi dive deep into the complexities of lymphangioleiomyomatosis (LAM), a rare and progressive cystic lung disease primarily affecting women of childbearing age. Dr. Ussavarungsi, Di ... Show More
24m 25s
Nov 3
2025 CHEST Conference Highlights
2025 CHEST Conference Highlights In this episode, pulmonary and critical care leaders share the most exciting takeaways from the CHEST annual meeting—where innovation and practical insights meet bedside care. Our experts discuss sessions that cover real-world strategies for manag ... Show More
18m 32s
Oct 22
Managing Respiratory Distress in Pregnancy in the Emergency Department
This podcast delivers a high-impact, practical discussion on managing critically ill pregnant patients—an area often outside the daily comfort zone of many pulmonary and critical care physicians. From recognizing subtle red flags like mild hypertension and tachypnea to navigating ... Show More
26m 33s
Apr 2025
STRIDE Trial: Effects of Semaglutide in Patients With Peripheral Artery Disease
Patients with peripheral artery disease (PAD) often experience significant walking difficulties, and there are limited therapies available to improve their mobility. Investigation made through the STRIDE (Effects of Semaglutide on Functional Capacity in Patients With Type 2 Diabe ... Show More
10m 8s
Jan 2025
409. Journal Club: The ARREST-AF Trial with Drs. Prashanthan Sanders and Mehak Dhande
Join CardioNerds EP Council Chair Dr. Naima Maqsood and Episode Lead Dr. Jeanne De Lavallaz as they discuss the results of the ARREST-AF Trial with expert faculty Dr. Prashanthan Sanders and Dr. Mehak Dhande. Audio editing by CardioNerds intern Bhavya Shah. The ARREST-AF trial en ... Show More
36m 4s
Jul 2024
Zone 2 training: impact on longevity and mitochondrial function, how to dose frequency and duration, and more | Iñigo San-Millán, Ph.D. (#201 rebroadcast)
2h 46m
Nov 13
New Research: Mitochondrial DNA in TRALI and Venetoclax-Obinituzumab in CLL Trials
In this week's episode, associate editor Dr. James Griffin interviews researchers Dr. John Semple and Dr. Othman Al-Sawaf on their groundbreaking studies on transfusion-related acute lung injury and chronic lymphocytic leukemia treatment. Dr. Semple explored how mitochondrial DNA ... Show More
18m 36s
Aug 2025
Common Medications and Diabetic Macular Edema
Dr. Drew Carey interviews medical student Jawad Muayad and Dr. Sami S. Dahr on the impact of systemic medications, including glucagon-like peptide-1 receptor agonists, fenofibrates, thiazolidinediones, and calcium channel blockers, on the risk of developing diabetic macular edema ... Show More
18m 26s
Aug 2025
Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes
Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed.
29m 55s
Feb 2025
#337 - Insulin resistance masterclass: The full body impact of metabolic dysfunction and prevention, diagnosis, and treatment | Ralph DeFronzo, M.D.
2h 26m
Jun 2025
PRAGUE-25 Trial: Catheter Ablation Versus Antiarrhythmic Drugs With Risk Factor Modification for Treatment of AF
12m 59s
Nov 2020
Covid-19 and comorbidities
A recent meta-analysis by Espinosa and colleagues, “Prevalence of Comorbidities in Patients and Mortality Cases Affected by SARS-CoV2”, found that 42% of patients with Covid-19 had comorbidities. Furthermore, 61% of those with Covid-19 admitted to the Intensive Care Unit had como ... Show More
14m 43s
Jun 2025
Dapagliflozin in Patients Undergoing Transcatheter Aortic Valve Implantation
The DapaTAVI trial, conducted across 39 centers in Spain, is the first study to evaluate the use of sodium-glucose co-transporter-2 (SGLT-2) inhibitors, specifically dapagliflozin, in patients with heart failure undergoing transcatheter aortic valve implantation (TAVI). The trial ... Show More
9m 4s
Dr. Amy Attaway and Dr. Dan Culver review the emerging relationship between COPD patients who have intermittent hypoxemia and an increase they have in co-morbidities and mortality. They discuss how multiple associative studies suggest that intermittent hypoxemia may impact musculature, cardiovascular and neurologic systems. Dr. Attaway and Dr. Culver also un ... Show More
<p><a href= "https://peterattiamd.com/inigosanmillan2/?utm_source=podcast-feed&utm_medium=referral&utm_campaign=240608-pod-inigosanmillan2&utm_content=240608-pod-inigosanmillan2-podfeed"> View the Show Notes Page for This Episode</a></p> <p><a href= "https://peterattiamd.com/subs ... Show More
<p><a href= "https://peterattiamd.com/ralphdefronzo/?utm_source=podcast-feed&utm_medium=referral&utm_campaign=250224-pod-ralphdefronzo&utm_content=250224-pod-ralphdefronzo-podfeed"> View the Show Notes Page for This Episode</a></p> <p><a href= "https://peterattiamd.com/subscribe/ ... Show More
<div class="OutlineElement Ltr SCXW209201394 BCX0"> <p class="Paragraph SCXW209201394 BCX0"><span class= "TextRun SCXW209201394 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class= "NormalTextRun SCXW209201394 BCX0">The PRAGUE-25</span> <span class="NormalTextRun ... Show More
